Skip to content
Sign in

HCAT · NASDAQ

Health Catalyst (HCAT) Stock Price & Fundamentals

$564.60−0.76%−$4.33End-of-day price as of Oct 9, 2026

Health Catalyst (HCAT) closed at $564.60 on Oct 9, 2026, down 0.76% from the previous close of $568.93.

Share price, past year

1Y +23.05%

52-week range $429.28 – $568.93. Daily closing prices.
Monthly closing prices
Last closing price of each month
DateClose
Oct 9, 2026$564.60
Sep 30, 2026$546.16
Aug 31, 2026$493.84
Jul 31, 2026$480.01
Jun 30, 2026$464.73
May 29, 2026$465.16
Apr 30, 2026$463.63
Mar 31, 2026$498.31
Feb 27, 2026$502.18
Jan 30, 2026$486.15
Dec 31, 2025$502.34
Nov 28, 2025$465.38
Oct 31, 2025$449.11

Key statistics

Market cap
$42.12B
P/E (TTM)
—
EPS (TTM)
−$3.69
Revenue (TTM)
$292.25M
Net income (TTM)
−$264.82M
Shares outstanding
74.6M
Dividend yield
—
52-week range
$429.28 – $568.93

Health Catalyst's market cap is $42.12B, based on a share price of $564.60 and 74.6M shares outstanding as of Jun 30, 2026.

Financials

Health Catalyst reported revenue of $311.14M for fiscal 2025, up 1.48% from fiscal 2024.

Health Catalyst reported a net loss of $177.97M in fiscal 2025.

Fiscal 2025 revenue was the highest in the 9 years shown.

Annual revenue

FY17FY18FY19FY20FY21FY22FY23FY24FY25
Annual revenue by fiscal year; the table below lists the values.
Health Catalyst annual financials by fiscal year, from SEC filings
Fiscal yearRevenueGrowthNet incomeNet marginEPS (diluted)Free cash flow
FY2025ended Dec 31, 2025$311.14M+1.5%−$177.97M−57.2%−$2.55−$237.00K
FY2024ended Dec 31, 2024$306.58M+3.6%−$69.50M−22.7%−$1.15$12.94M
FY2023ended Dec 31, 2023$295.94M+7.1%−$118.15M−39.9%−$2.09−$34.32M
FY2022ended Dec 31, 2022$276.24M+14.2%−$137.40M−49.7%−$2.63−$37.44M
FY2021ended Dec 31, 2021$241.93M+28.1%−$153.21M−63.3%−$3.23−$33.57M
FY2020ended Dec 31, 2020$188.85M+21.9%−$115.02M−60.9%−$2.91−$33.92M
FY2019ended Dec 31, 2019$154.94M+37.6%−$60.10M−38.8%−$12.86−$34.20M
FY2018ended Dec 31, 2018$112.57M+54.0%−$61.98M−55.1%−$23.76−$42.37M
FY2017ended Dec 31, 2017$73.08M—−$47.04M−64.4%−$12.13−$39.30M
Health Catalyst quarterly results
QuarterRevenueNet incomeEPS (diluted)
Q2 FY2026ended Jun 30, 2026$70.49M−$40.54M−$0.55
Q1 FY2026ended Mar 31, 2026$70.76M−$111.03M−$1.53
Q4 FY2025ended Dec 31, 2025$74.68M−$91.03M−$1.29
Q3 FY2025ended Sep 30, 2025$76.32M−$22.23M−$0.32
Q2 FY2025ended Jun 30, 2025$80.72M−$40.98M−$0.59
Q1 FY2025ended Mar 31, 2025$79.41M−$23.74M−$0.35
Q4 FY2024ended Dec 31, 2024$79.61M−$20.67M−$0.33
Q3 FY2024ended Sep 30, 2024$76.35M−$14.73M−$0.24

Company profile

Name
Health Catalyst, Inc.
Ticker
HCAT
Exchange
NASDAQ
Industry (SEC SIC)
Services-Computer Programming, Data Processing, Etc.
Headquarters
10897 South River Front Parkway, #300, South Jordan, UT 84095
Incorporated in
DE
Fiscal year ends
December
SEC CIK
0001636422

Recent SEC filings

Frequently asked questions

What is Health Catalyst's stock price?

Health Catalyst (HCAT) closed at $564.60 on Oct 9, 2026, down 0.76% from the previous close of $568.93.

What is Health Catalyst's market cap?

Health Catalyst's market cap is $42.12B, based on a share price of $564.60 and 74.6M shares outstanding as of Jun 30, 2026.

How much revenue does Health Catalyst make?

Health Catalyst reported revenue of $311.14M for fiscal 2025, up 1.48% from fiscal 2024.

Does Health Catalyst pay a dividend?

Health Catalyst's recent filings report no dividends declared over the last four quarters.

Sources and methodology

Fundamentals come from Health Catalyst, Inc.'s filings with the SEC (EDGAR XBRL company facts). Fourth-quarter figures that companies don't report separately are calculated as the fiscal year minus the first three quarters. Trailing twelve-month (TTM) figures sum the latest four quarters. Prices are generated sample data for development. Last updated Oct 9, 2026. Data sources and disclosures